SILVER SPRING, Md., Nov. 28, 2023 /PRNewswire/ — Today, as part of the U.S. Food and Drug Administration’s continued commitment to protect and promote the public health, the agency is alerting patients and healthcare providers of an emerging safety issue involving Philips Respironics’…